Search our
Current Studies

Still have questions some about the process? Review our Frequently Asked Questions for the answers.
Learn More
Image

A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn’s Disease (CARMEN CD 305)

Location(s): Flager Hospital, St. Augustine

Condition: Crohn's disease, Gastrointestinal Disease

A Trial to Evaluate the Efficacy and Safety of the Oral sGC stImulator Vericiguat to Improve Physical Functioning in Activities of Daily Living in Patients With Heart Failure and Preserved Ejection Fraction (VITALITY-HFpEF)

Location(s): Flagler Hospital

Condition: Heart Disease, Heart Failure

The purpose of the study is to collect data about how well U-100 Regular Human Insulin can be used in the V-Go Insulin Delivery Device compared to U-100 Rapid Acting Insulin in the V-Go Insulin Delivery Device. The data collected will be used to see how much subjects’ blood sugar levels change over time after they switch from using U-100 Rapid Acting Insulin to U-100 Regular Human Insulin within their V-Go Insulin Delivery Device.

Location(s): Macon, Memorial Hospital

Condition: Diabetes

A Phase III Trial to Evaluate the Effect of EMPagliflozin 10 mg Compared With Placebo on ExeRcise Ability and Heart Failure Symptoms, In Patients With Chronic HeArt FaiLure With Reduced Ejection Fraction (HFrEF) (EMPERIAL-reduced)

Location(s): Flagler Hospital

Condition: Heart Disease, Heart Failure

A Phase III Trial to Evaluate the Effect of EMPagliflozin 10 mg Compared With Placebo on ExeRcise Ability and Heart Failure Symptoms, In Patients With Chronic HeArt FaiLure With Preserved Ejection Fraction (HFpEF) (EMPERIAL – Preserved)

Location(s): Flagler Hospital

Condition: Heart Disease, Heart Failure

A Phase 2 Study to Evaluate the Safety and Efficacy of IW-1973 in Patients With Type 2 Diabetes With Albuminuria Treated With Renin-Angiotensin System Inhibitors

Location(s): Macon

Condition: Diabetes, Kidney Disease

A Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk

Location(s): LaVilla, Macon, Memorial Hospital

Condition: Diabetes

A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD

Location(s): LaVilla

Condition: Diabetes, Kidney Disease

A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of hemoglobin (Hb) in subjects with NDD-CKD

Location(s): LaVilla

Condition: Diabetes, Kidney Disease

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Location(s): Memorial Hospital

Condition: Heart Disease, Heart Failure

Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin (SOTA-EMPA)

Location(s): Macon

Condition: Diabetes

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease (FIGARO-DKD)

Location(s): LaVilla, Macon

Condition: Diabetes, Kidney Disease

A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)

Location(s): Flagler Hospital

Condition: Gastrointestinal Disease, Ulcerative Colitis

A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) (VICTORIA)

Location(s): Flagler Hospital, Memorial Hospital

Condition: Heart Disease, Heart Failure

A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (CAPACITY-HFpEF)

Location(s): Memorial Hospital

Condition: Heart Disease, Heart Failure